NO20042755L - Amidsubstituerte imidazopyridiner - Google Patents

Amidsubstituerte imidazopyridiner

Info

Publication number: NO20042755L
Authority: NO; Norway
Prior art keywords: amide; substituted imidazopyridines; imidazopyridines; substituted
Prior art date: 2001-12-06

Application number

NO20042755A

Other languages

English (en)

Inventor

Kyle J Lindstrom

Philip D Heppner

Jr Joseph F Dellaria

Chad A Haraldson

Original Assignee

3M Innovative Properties Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-06

Filing date

2004-06-29

Publication date

2004-06-29

2004-06-29 Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co

2004-06-29 Publication of NO20042755L publication Critical patent/NO20042755L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Dermatology (AREA)
Hematology (AREA)
Tropical Medicine & Parasitology (AREA)
Biotechnology (AREA)
AIDS & HIV (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Otolaryngology (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20042755A 2001-12-06 2004-06-29 Amidsubstituerte imidazopyridiner NO20042755L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10/016,073 US20020107262A1 (en)	2000-12-08	2001-12-06	Substituted imidazopyridines
PCT/US2002/018282 WO2003050118A1 (en)	2001-12-06	2002-06-07	Amide substituted imidazopyridines

Publications (1)

Publication Number	Publication Date
NO20042755L true NO20042755L (no)	2004-06-29

Family

ID=21775232

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
NO20042621A NO20042621L (no)	2001-12-06	2004-06-22	Sulfonamidosubstituerte imidazopyridiner
NO20042661A NO20042661L (no)	2001-12-06	2004-06-24	Ureasubstituerte imidazopyridiner
NO20042755A NO20042755L (no)	2001-12-06	2004-06-29	Amidsubstituerte imidazopyridiner

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
NO20042621A NO20042621L (no)	2001-12-06	2004-06-22	Sulfonamidosubstituerte imidazopyridiner
NO20042661A NO20042661L (no)	2001-12-06	2004-06-24	Ureasubstituerte imidazopyridiner

Country Status (18)

Country	Link
US (1)	US20020107262A1 (no)
EP (3)	EP1453829A1 (no)
JP (3)	JP2005513052A (no)
KR (3)	KR20040105695A (no)
CN (4)	CN100372846C (no)
AU (3)	AU2002312414B2 (no)
BR (3)	BR0214999A (no)
CA (3)	CA2468659A1 (no)
HR (3)	HRP20040503A2 (no)
IL (3)	IL161946A0 (no)
MX (3)	MXPA04005363A (no)
NO (3)	NO20042621L (no)
NZ (3)	NZ532927A (no)
PL (3)	PL370702A1 (no)
RU (3)	RU2004117161A (no)
UA (3)	UA77709C2 (no)
WO (3)	WO2003050119A2 (no)
ZA (3)	ZA200405336B (no)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2488801A1 (en)	2002-06-07	2003-12-18	3M Innovative Properties Company	Ether substituted imidazopyridines
HRP20050696B1 (en)	2003-01-14	2008-10-31	Arena Pharmaceuticals Inc.	1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US20040265351A1 (en)	2003-04-10	2004-12-30	Miller Richard L.	Methods and compositions for enhancing immune response
EP1615665A4 (en) *	2003-04-10	2010-10-06	3M Innovative Properties Co	DISTRIBUTION OF THE IMMUNE RESPONSE MODIFYING LINKS
AR045047A1 (es)	2003-07-11	2005-10-12	Arena Pharm Inc	Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
AU2004266641A1 (en)	2003-08-12	2005-03-03	3M Innovative Properties Company	Oxime substituted imidazo-containing compounds
WO2005018555A2 (en) *	2003-08-14	2005-03-03	3M Innovative Properties Company	Lipid-modified immune response modifiers
EP1658076B1 (en)	2003-08-27	2013-03-06	3M Innovative Properties Company	Aryloxy and arylalkyleneoxy substituted imidazoquinolines
US20050054665A1 (en)	2003-09-05	2005-03-10	3M Innovative Properties Company	Treatment for CD5+ B cell lymphoma
KR20060120069A (ko)	2003-10-03	2006-11-24	쓰리엠 이노베이티브 프로퍼티즈 컴파니	피라졸로피리딘 및 그의 유사체
ES2544477T3 (es)	2003-10-03	2015-08-31	3M Innovative Properties Company	Imidazoquinolinas sustituidas con alcoxi
US7544697B2 (en)	2003-10-03	2009-06-09	Coley Pharmaceutical Group, Inc.	Pyrazolopyridines and analogs thereof
EP1678137A1 (en) *	2003-10-15	2006-07-12	Chiron Corporation	Compositions and methods for viral inhibition
US7897767B2 (en) *	2003-11-14	2011-03-01	3M Innovative Properties Company	Oxime substituted imidazoquinolines
JP2007511535A (ja)	2003-11-14	2007-05-10	スリーエムイノベイティブプロパティズカンパニー	ヒドロキシルアミン置換イミダゾ環化合物
CA2547085A1 (en) *	2003-11-25	2005-06-09	3M Innovative Properties Company	Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
RU2409576C2 (ru)	2003-11-25	2011-01-20	3М Инновейтив Пропертиз Компани	Системы, содержащие имидазольное кольцо с заместителями, и способы их получения
CA2549216A1 (en) *	2003-12-04	2005-08-25	3M Innovative Properties Company	Sulfone substituted imidazo ring ethers
WO2005066170A1 (en)	2003-12-29	2005-07-21	3M Innovative Properties Company	Arylalkenyl and arylalkynyl substituted imidazoquinolines
EP1699792A1 (en) *	2003-12-29	2006-09-13	3M Innovative Properties Company	Piperazine, 1,4¨diazepane, 1,4¨diazocane, and 1,5¨diazocane fused imidazo ring compounds
CA2551399A1 (en)	2003-12-30	2005-07-21	3M Innovative Properties Company	Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
EP1730143A2 (en)	2004-03-24	2006-12-13	3M Innovative Properties Company	Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123079A2 (en) *	2004-06-14	2005-12-29	3M Innovative Properties Company	Urea substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en)	2004-06-15	2005-12-29	3M Innovative Properties Company	Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006038923A2 (en)	2004-06-18	2006-04-13	3M Innovative Properties Company	Aryl substituted imidazonaphthyridines
US7884207B2 (en) *	2004-06-18	2011-02-08	3M Innovative Properties Company	Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
WO2006009826A1 (en)	2004-06-18	2006-01-26	3M Innovative Properties Company	Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US8541438B2 (en)	2004-06-18	2013-09-24	3M Innovative Properties Company	Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
WO2006065280A2 (en)	2004-06-18	2006-06-22	3M Innovative Properties Company	Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
PL1789042T3 (pl) *	2004-09-02	2012-09-28	3M Innovative Properties Co	Układy pierścieni 1-alkoksy 1H-imidazo i sposoby
CA2578975A1 (en)	2004-09-02	2006-03-16	3M Innovative Properties Company	2-amino 1h imidazo ring systems and methods
US20070243215A1 (en) *	2004-10-08	2007-10-18	Miller Richard L	Adjuvant for Dna Vaccines
AU2005326708C1 (en)	2004-12-30	2012-08-30	3M Innovative Properties Company	Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
US8436176B2 (en) *	2004-12-30	2013-05-07	Medicis Pharmaceutical Corporation	Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
US8461174B2 (en) *	2004-12-30	2013-06-11	3M Innovative Properties Company	Treatment for cutaneous metastases
NZ556399A (en) *	2004-12-30	2009-03-31	Takeda Pharmaceutical	1-(2-methylpropyl)-1H-imidazo[4,5-C][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1H-imidazo[4,5-C][1,5]naphthyridin-4-amine methanesulfonate
CA2592904C (en)	2004-12-30	2015-04-07	3M Innovative Properties Company	Chiral fused [1,2]imidazo[4,5-c] ring compounds
US9248127B2 (en)	2005-02-04	2016-02-02	3M Innovative Properties Company	Aqueous gel formulations containing immune response modifiers
JP2008530252A (ja)	2005-02-09	2008-08-07	コーリーファーマシューティカルグループ，インコーポレイテッド	オキシムおよびヒドロキシルアミンで置換されたチアゾロ［４，５−ｃ］環化合物ならびに方法
WO2006086449A2 (en)	2005-02-09	2006-08-17	Coley Pharmaceutical Group, Inc.	Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006091394A2 (en)	2005-02-11	2006-08-31	Coley Pharmaceutical Group, Inc.	Substituted imidazoquinolines and imidazonaphthyridines
WO2006086634A2 (en)	2005-02-11	2006-08-17	Coley Pharmaceutical Group, Inc.	Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
JP2008538203A (ja)	2005-02-23	2008-10-16	コーリーファーマシューティカルグループ，インコーポレイテッド	インターフェロンの生合成を優先的に誘導する方法
WO2006098852A2 (en)	2005-02-23	2006-09-21	Coley Pharmaceutical Group, Inc.	Hydroxyalkyl substituted imidazoquinolines
EP1851218A2 (en)	2005-02-23	2007-11-07	3M Innovative Properties Company	Hydroxyalkyl substituted imidazoquinoline compounds and methods
EP1851220A2 (en)	2005-02-23	2007-11-07	3M Innovative Properties Company	Hydroxyalkyl substituted imidazonaphthyridines
AU2006232375A1 (en)	2005-04-01	2006-10-12	Coley Pharmaceutical Group, Inc.	1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
US7943610B2 (en)	2005-04-01	2011-05-17	3M Innovative Properties Company	Pyrazolopyridine-1,4-diamines and analogs thereof
JP2008539252A (ja) *	2005-04-25	2008-11-13	スリーエムイノベイティブプロパティズカンパニー	免疫活性化組成物
ZA200803029B (en)	2005-09-09	2009-02-25	Coley Pharm Group Inc	Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
EA200800782A1 (ru)	2005-09-09	2008-08-29	Коли Фармасьютикал Груп, Инк.	ПРОИЗВОДНЫЕ АМИДА И КАРБАМАТА N-{2-[4-АМИНО-2-(ЭТОКСИМЕТИЛ)-1Н-ИМИДАЗОЛО[4,5-c]ХИНОЛИН-1-IL]-1,1-ДИМЕТИЛЭТИЛ}МЕТАНСУЛЬФОНАМИДА И СПОСОБЫ
CN100344325C (zh) *	2005-10-17	2007-10-24	华南师范大学	一种治疗宫颈癌的药物及其制备方法与应用
WO2007056112A2 (en)	2005-11-04	2007-05-18	Coley Pharmaceutical Group, Inc.	Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
WO2007100634A2 (en)	2006-02-22	2007-09-07	3M Innovative Properties Company	Immune response modifier conjugates
US8329721B2 (en)	2006-03-15	2012-12-11	3M Innovative Properties Company	Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods
US7906506B2 (en)	2006-07-12	2011-03-15	3M Innovative Properties Company	Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
EP2054060B1 (en) *	2006-08-24	2014-04-02	Australian Nuclear Science & Technology Organisation	Fluorinated ligands for targeting peripheral benzodiazepine receptors
WO2008030511A2 (en)	2006-09-06	2008-03-13	Coley Pharmaceuticial Group, Inc.	Substituted 3,4,6,7-tetrahydro-5h, 1,2a,4a,8-tetraazacyclopenta[cd]phenalenes
GB0625827D0 (en) *	2006-12-22	2007-02-07	Astex Therapeutics Ltd	New compounds
HRP20151398T1 (hr)	2006-12-22	2016-02-12	Astex Therapeutics Limited	Tricikliäśni derivati amina kao inhibitori protein tirozin kinaze
US20080149123A1 (en) *	2006-12-22	2008-06-26	Mckay William D	Particulate material dispensing hairbrush with combination bristles
CN101679408B (zh)	2006-12-22	2016-04-27	Astex治疗学有限公司	作为fgfr抑制剂的双环杂环化合物
GB0720041D0 (en)	2007-10-12	2007-11-21	Astex Therapeutics Ltd	New Compounds
GB0720038D0 (en)	2007-10-12	2007-11-21	Astex Therapeutics Ltd	New compounds
CN101239978A (zh) *	2008-03-05	2008-08-13	南方医科大学	一种咪唑并吡啶类化合物
GB0810902D0 (en)	2008-06-13	2008-07-23	Astex Therapeutics Ltd	New compounds
GB0906470D0 (en)	2009-04-15	2009-05-20	Astex Therapeutics Ltd	New compounds
GB0906472D0 (en)	2009-04-15	2009-05-20	Astex Therapeutics Ltd	New compounds
WO2011076784A2 (en) *	2009-12-21	2011-06-30	Institut National De La Sante Et De La Recherche Medicale (Inserm)	New inhibitors of cyclophilins and uses thereof
HRP20170433T1 (hr)	2010-08-17	2017-05-05	3M Innovative Properties Company	Pripravci spoja za izmjenu lipidiranog imunološkog odgovora, formulacije, i postupci
MX2013003184A (es)	2010-09-22	2013-06-07	Arena Pharm Inc	Moduladores del receptor gpr119 y el tratamiento de transtornos relacionados con el mismo.
CN103582496B (zh)	2011-06-03	2016-05-11	3M创新有限公司	具有聚乙二醇链段的异双官能连接基以及由其制成的免疫应答调节剂缀合物
WO2012167081A1 (en)	2011-06-03	2012-12-06	3M Innovative Properties Company	Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom
WO2015023958A1 (en) *	2013-08-15	2015-02-19	The University Of Kansas	Toll-like receptor agonists
US11007175B2 (en)	2015-01-06	2021-05-18	Arena Pharmaceuticals, Inc.	Methods of treating conditions related to the S1P1 receptor
BR112017027656B1 (pt)	2015-06-22	2023-12-05	Arena Pharmaceuticals, Inc.	Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo
WO2018107173A1 (en) *	2016-12-09	2018-06-14	Vanderbilt University	Glutamine transport inhibitors and methods for treating cancer
CA3053418A1 (en)	2017-02-16	2018-08-23	Arena Pharmaceuticals, Inc.	Compounds and methods for treatment of primary biliary cholangitis
EP3728255B1 (en)	2017-12-20	2022-01-26	3M Innovative Properties Company	Amide substituted imidazo[4,5-c]quinoline compounds with a branched chain linking group for use as an immune response modifier
BR112020024762A2 (pt)	2018-06-06	2021-03-23	Arena Pharmaceuticals, Inc.	métodos de tratamento de condições relacionadas ao receptor s1p1

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2167042A1 (en) *	1993-07-15	1995-01-26	Kyle J. Lindstrom	Imidazo[4,5-c]pyridin-4-amines
CZ294563B6 (cs) *	1996-10-25	2005-02-16	Minnesota Mining And Manufacturing Company	Sloučeniny představující modifikátory imunitní odezvy při léčení nemocí mediovaných TH2 buňkami a nemocí odvozených
US6331539B1 (en) *	1999-06-10	2001-12-18	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
US6451810B1 (en) *	1999-06-10	2002-09-17	3M Innovative Properties Company	Amide substituted imidazoquinolines
US6541485B1 (en) *	1999-06-10	2003-04-01	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6376669B1 (en) *	1999-11-05	2002-04-23	3M Innovative Properties Company	Dye labeled imidazoquinoline compounds
UA74593C2 (en) *	2000-12-08	2006-01-16	3M Innovative Properties Co	Substituted imidazopyridines

2001
- 2001-12-06 US US10/016,073 patent/US20020107262A1/en not_active Abandoned
2002
- 2002-06-07 CN CNB028242866A patent/CN100372846C/zh not_active Expired - Fee Related
- 2002-06-07 NZ NZ532927A patent/NZ532927A/en unknown
- 2002-06-07 CA CA002468659A patent/CA2468659A1/en not_active Abandoned
- 2002-06-07 AU AU2002312414A patent/AU2002312414B2/en not_active Expired - Fee Related
- 2002-06-07 RU RU2004117161/04A patent/RU2004117161A/ru not_active Application Discontinuation
- 2002-06-07 BR BR0214999-0A patent/BR0214999A/pt not_active IP Right Cessation
- 2002-06-07 IL IL16194602A patent/IL161946A0/xx unknown
- 2002-06-07 HR HRP20040503 patent/HRP20040503A2/hr not_active Application Discontinuation
- 2002-06-07 PL PL02370702A patent/PL370702A1/xx not_active Application Discontinuation
- 2002-06-07 BR BR0214752-1A patent/BR0214752A/pt not_active IP Right Cessation
- 2002-06-07 CN CNB028242874A patent/CN100387597C/zh not_active Expired - Fee Related
- 2002-06-07 EP EP02739783A patent/EP1453829A1/en not_active Withdrawn
- 2002-06-07 CA CA002468164A patent/CA2468164A1/en not_active Abandoned
- 2002-06-07 IL IL16194502A patent/IL161945A0/xx unknown
- 2002-06-07 MX MXPA04005363A patent/MXPA04005363A/es unknown
- 2002-06-07 AU AU2002345615A patent/AU2002345615B2/en not_active Expired - Fee Related
- 2002-06-07 JP JP2003551141A patent/JP2005513052A/ja active Pending
- 2002-06-07 JP JP2003551142A patent/JP2005511745A/ja active Pending
- 2002-06-07 EP EP02741939A patent/EP1451186A2/en not_active Withdrawn
- 2002-06-07 CN CNA2008100030374A patent/CN101220028A/zh active Pending
- 2002-06-07 PL PL02374260A patent/PL374260A1/xx not_active Application Discontinuation
- 2002-06-07 KR KR10-2004-7008676A patent/KR20040105695A/ko not_active Ceased
- 2002-06-07 KR KR10-2004-7008644A patent/KR20040105694A/ko not_active Ceased
- 2002-06-07 HR HRP20040506 patent/HRP20040506A2/hr not_active Application Discontinuation
- 2002-06-07 AU AU2002315006A patent/AU2002315006B2/en not_active Expired - Fee Related
- 2002-06-07 BR BR0214749-1A patent/BR0214749A/pt not_active IP Right Cessation
- 2002-06-07 CA CA002468174A patent/CA2468174A1/en not_active Abandoned
- 2002-06-07 EP EP02744260A patent/EP1451187A1/en not_active Withdrawn
- 2002-06-07 WO PCT/US2002/018284 patent/WO2003050119A2/en not_active Ceased
- 2002-06-07 PL PL02370738A patent/PL370738A1/xx not_active Application Discontinuation
- 2002-06-07 MX MXPA04005412A patent/MXPA04005412A/es not_active Application Discontinuation
- 2002-06-07 RU RU2004117159/04A patent/RU2004117159A/ru not_active Application Discontinuation
- 2002-06-07 RU RU2004117156/04A patent/RU2004117156A/ru not_active Application Discontinuation
- 2002-06-07 WO PCT/US2002/018282 patent/WO2003050118A1/en not_active Ceased
- 2002-06-07 JP JP2003551143A patent/JP2005511746A/ja active Pending
- 2002-06-07 NZ NZ532926A patent/NZ532926A/en unknown
- 2002-06-07 HR HRP20040504 patent/HRP20040504A2/hr not_active Application Discontinuation
- 2002-06-07 KR KR10-2004-7008686A patent/KR20040105696A/ko not_active Ceased
- 2002-06-07 IL IL16178702A patent/IL161787A0/xx unknown
- 2002-06-07 CN CNB028242858A patent/CN100402528C/zh not_active Expired - Fee Related
- 2002-06-07 WO PCT/US2002/018220 patent/WO2003050117A1/en not_active Ceased
- 2002-06-07 MX MXPA04005331A patent/MXPA04005331A/es unknown
- 2002-06-07 NZ NZ532770A patent/NZ532770A/en unknown
- 2002-07-06 UA UA20040604339A patent/UA77709C2/uk unknown
- 2002-07-06 UA UA20040604343A patent/UA77711C2/uk unknown
- 2002-07-06 UA UA20040604342A patent/UA77710C2/uk unknown
2004
- 2004-06-22 NO NO20042621A patent/NO20042621L/no not_active Application Discontinuation
- 2004-06-24 NO NO20042661A patent/NO20042661L/no not_active Application Discontinuation
- 2004-06-29 NO NO20042755A patent/NO20042755L/no not_active Application Discontinuation
- 2004-07-05 ZA ZA200405336A patent/ZA200405336B/en unknown
- 2004-07-05 ZA ZA200405337A patent/ZA200405337B/en unknown
- 2004-07-05 ZA ZA200405334A patent/ZA200405334B/en unknown

Also Published As

Publication number	Publication date
BR0214749A (pt)	2004-08-31
NZ532927A (en)	2006-06-30
PL370702A1 (en)	2005-05-30
BR0214752A (pt)	2005-08-02
KR20040105696A (ko)	2004-12-16
KR20040105695A (ko)	2004-12-16
CN100372846C (zh)	2008-03-05
CN1599739A (zh)	2005-03-23
AU2002312414A1 (en)	2003-06-23
EP1451187A1 (en)	2004-09-01
NZ532770A (en)	2006-07-28
JP2005513052A (ja)	2005-05-12
JP2005511745A (ja)	2005-04-28
BR0214999A (pt)	2004-12-28
IL161946A0 (en)	2005-11-20
UA77711C2 (en)	2007-01-15
AU2002315006B2 (en)	2009-01-29
CA2468659A1 (en)	2003-06-19
CN1599738A (zh)	2005-03-23
CN101220028A (zh)	2008-07-16
CN100387597C (zh)	2008-05-14
ZA200405336B (en)	2006-12-27
PL374260A1 (en)	2005-10-03
KR20040105694A (ko)	2004-12-16
EP1451186A2 (en)	2004-09-01
WO2003050119A2 (en)	2003-06-19
PL370738A1 (en)	2005-05-30
RU2004117156A (ru)	2006-01-10
MXPA04005331A (es)	2004-09-13
WO2003050118A1 (en)	2003-06-19
ZA200405337B (en)	2006-12-27
MXPA04005412A (es)	2004-10-11
EP1453829A1 (en)	2004-09-08
AU2002345615B2 (en)	2009-01-15
CN1599740A (zh)	2005-03-23
NO20042661L (no)	2004-06-24
UA77710C2 (en)	2007-01-15
CA2468174A1 (en)	2003-06-19
NO20042621L (no)	2004-06-22
CN100402528C (zh)	2008-07-16
RU2004117159A (ru)	2006-01-10
WO2003050119A3 (en)	2003-07-10
IL161945A0 (en)	2005-11-20
RU2004117161A (ru)	2005-05-10
HRP20040504A2 (en)	2004-12-31
AU2002315006A1 (en)	2003-06-23
IL161787A0 (en)	2005-11-20
AU2002345615A1 (en)	2003-06-23
HRP20040503A2 (en)	2004-12-31
CA2468164A1 (en)	2003-06-19
HRP20040506A2 (en)	2004-12-31
JP2005511746A (ja)	2005-04-28
WO2003050117A1 (en)	2003-06-19
US20020107262A1 (en)	2002-08-08
MXPA04005363A (es)	2004-09-27
UA77709C2 (en)	2007-01-15
ZA200405334B (en)	2006-12-27
NZ532926A (en)	2006-06-30
AU2002312414B2 (en)	2009-02-19

Publication	Publication Date	Title
NO20042755L (no)	2004-06-29	Amidsubstituerte imidazopyridiner
NO20035476D0 (no)	2003-12-09	Azaindoler
NO20032453L (no)	2003-07-16	Substituerte imidazopyridiner
DE60208775D1 (de)	2006-04-06	Formgedächtnisstyrolcopolymer
DE60223682D1 (de)	2008-01-03	Tintenstrahldrucktintenset
DE60237979D1 (de)	2010-11-25	Ausgussbehälter
DE50103741D1 (de)	2004-10-28	Welle-Nabe-Verbindung
DE50206021D1 (de)	2006-05-04	Schlauchklemme
DE60228157D1 (de)	2008-09-25	Berstschutzvorrichtung
DE60205841D1 (de)	2005-10-06	Perfluoroelastomere
DE50208287D1 (de)	2006-11-09	Bicyclische n-arylamide
DE60208317D1 (de)	2006-02-02	Ozonisator
DE60238336D1 (de)	2010-12-30	Zentrifugalbeschichtungsverfahren
DE60217049D1 (de)	2007-02-08	Ölluftseparatorplug
DE60215591D1 (de)	2006-12-07	Kraftsoffeinspritzventil
DE60130930D1 (de)	2007-11-22	Polarisationsmodendispersion-kompensator
DE60208269D1 (de)	2006-02-02	Flüssigkeitsströmungsreguliersystem
DE60217846D1 (de)	2007-03-15	Mastnutzlastandockstation
DE60235709D1 (de)	2010-04-29	Vorformapperat
ATA18372001A (de)	2005-07-15	Gelenksbolzenbaueinheit
DE60234854D1 (de)	2010-02-04	Genüberexpressionssystem
ATA13992002A (de)	2003-10-15	Schlackengranulierungsanlage
FIU20010206U0 (fi)	2001-05-21	Kaihdinmekanismi
DE60229395D1 (de)	2008-11-27	Altung
ES1050856Y (es)	2002-09-16	Burlete

Legal Events

Date	Code	Title	Description
2010-01-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application